Echarri, AnaVera, IsabelOllero, VirginiaArajol, ClaudiaRiestra, SabinoRobledo, PilarCalvo, MartaGallego, FransciscoCeballos, DanielCastro, BeatrizAguas, MariamGarcía-López, SantiagoMarín-Jiménez, IgnacioChaparro, MaríaMesonero, PacoGuerra, IvánGuardiola, JordiNos, PilarMuñiz, Javier2023-01-252023-01-252019-03-08http://hdl.handle.net/10668/13678Objectives: Mobile apps are useful tools in e-health and self-management strategies in disease monitoring. We evaluated the Harvey-Bradshaw index (HBI) mobile app self-administered by the patient to see if its results agreed with HBI in-clinic assessed by a physician. Methods: Patients were enrolled in a 4-month prospective study with clinical assessments at months 1 and 4. Patients completed mobile app HBI and within 48 h, HBI was performed by a physician (gold standard). HBI scores characterized Crohn's disease (CD) as remissionenAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/behavioral healthe-healthhome health monitoringtelehealthtelemedicineAdultAgedCrohn DiseaseHumansMaleMiddle AgedMobile ApplicationsProspective StudiesSelf-ManagementSeverity of Illness IndexSurveys and QuestionnairesTelemedicineresearch article30848700open access10.1089/tmj.2018.02641556-3669PMC6948001https://www.liebertpub.com/doi/pdf/10.1089/tmj.2018.0264https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948001/pdf